Chris Cooper
Stock Analyst at J.P. Morgan
(4.16)
# 1,521
Out of 4,575 analysts
174
Total ratings
62.5%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Chris Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: COH Cochlear Limited | Maintained: Hold | $111.00 → $119.40 | $114.50 | +4.28% | 11 | Jul 21, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $37.10 → $35.80 | $28.00 | +27.86% | 8 | Jul 21, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $28.99 → $45.42 | $39.88 | +13.88% | 9 | May 27, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $207.90 | $162.24 | +28.14% | 24 | May 18, 2026 | |
| RMD ResMed | Initiated Coverage: Buy | n/a | $195.27 | - | 5 | Apr 15, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Sell | $3.80 → $3.00 | $2.99 | n/a | 11 | Jan 24, 2024 | |
| ASX: HLS Healius Limited | Maintained: Hold | $2.90 → $1.40 | $0.35 | n/a | 11 | Jan 24, 2024 | |
| ASX: SHL Sonic Healthcare Limited | Initiated Coverage: Hold | $29.00 → $29.70 | $21.40 | n/a | 11 | Jan 24, 2024 | |
| ASX: CSL CSL Limited | Maintained: Buy | $307.00 → $309.00 | $116.39 | n/a | 13 | Dec 4, 2023 | |
| ASX: CYV Ceryvyn Therapeutics Limited | Maintained: Buy | $2.80 → $2.05 | $0.01 | n/a | 4 | Oct 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54.00 → $43.00 | $42.54 | n/a | 15 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $296 | $336.04 | n/a | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $5.53 | n/a | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.40 → $3.30 | $2.35 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.05 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.86 | n/a | 4 | Jul 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $234 | $20.00 | n/a | 1 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €116.03 | €166.15 | n/a | 1 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 106,611p → 113,743p | 1,148p | n/a | 4 | Jul 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $70 | $235.44 | n/a | 9 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 23,274p | 74p | n/a | 2 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $81 | $24.59 | n/a | 1 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 112,617p | 2,782p | n/a | 1 | Jun 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 60,588p | 298p | n/a | 1 | Jun 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $30.57 | n/a | 1 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 | $330.25 | n/a | 4 | Mar 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.2384 | n/a | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $91.35 | n/a | 1 | Feb 4, 2016 |
Cochlear Limited
Jul 21, 2026
Maintained: Hold
Price Target: $111.00 → $119.40
Current: $114.50
Upside: +4.28%
ResMed Inc.
Jul 21, 2026
Maintained: Buy
Price Target: $37.10 → $35.80
Current: $28.00
Upside: +27.86%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Buy
Price Target: $28.99 → $45.42
Current: $39.88
Upside: +13.88%
Pro Medicus Limited
May 18, 2026
Maintained: Buy
Price Target: $207.90
Current: $162.24
Upside: +28.14%
ResMed
Apr 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $195.27
Upside: -
Nanosonics Limited
Jan 24, 2024
Reiterated: Sell
Price Target: $3.80 → $3.00
Current: $2.99
Upside: n/a
Healius Limited
Jan 24, 2024
Maintained: Hold
Price Target: $2.90 → $1.40
Current: $0.35
Upside: n/a
Sonic Healthcare Limited
Jan 24, 2024
Initiated Coverage: Hold
Price Target: $29.00 → $29.70
Current: $21.40
Upside: n/a
CSL Limited
Dec 4, 2023
Maintained: Buy
Price Target: $307.00 → $309.00
Current: $116.39
Upside: n/a
Ceryvyn Therapeutics Limited
Oct 15, 2023
Maintained: Buy
Price Target: $2.80 → $2.05
Current: $0.01
Upside: n/a
Aug 24, 2023
Reiterated: Sell
Price Target: $54.00 → $43.00
Current: $42.54
Upside: n/a
Aug 15, 2023
Maintained: Hold
Price Target: $296
Current: $336.04
Upside: n/a
Apr 28, 2023
Maintained: Sell
Price Target: n/a
Current: $5.53
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $3.40 → $3.30
Current: $2.35
Upside: n/a
Feb 17, 2023
Maintained: Buy
Price Target: $3.30
Current: $2.05
Upside: n/a
Jul 17, 2021
Maintained: Hold
Price Target: n/a
Current: $14.86
Upside: n/a
Mar 24, 2020
Maintained: Buy
Price Target: $234
Current: $20.00
Upside: n/a
Aug 9, 2017
Maintained: Buy
Price Target: €116.03
Current: €166.15
Upside: n/a
Jul 28, 2017
Reiterated: Buy
Price Target: 106,611p → 113,743p
Current: 1,148p
Upside: n/a
Jun 26, 2017
Downgraded: Hold
Price Target: $70
Current: $235.44
Upside: n/a
Aug 5, 2016
Reiterated: Buy
Price Target: 23,274p
Current: 74p
Upside: n/a
Jul 8, 2016
Upgraded: Hold
Price Target: $81
Current: $24.59
Upside: n/a
Jun 9, 2016
Reiterated: Buy
Price Target: 112,617p
Current: 2,782p
Upside: n/a
Jun 9, 2016
Reiterated: Buy
Price Target: 60,588p
Current: 298p
Upside: n/a
May 9, 2016
Upgraded: Buy
Price Target: n/a
Current: $30.57
Upside: n/a
Mar 7, 2016
Reiterated: Hold
Price Target: $100
Current: $330.25
Upside: n/a
Mar 3, 2016
Reiterated: Buy
Price Target: $11
Current: $0.2384
Upside: n/a
Feb 4, 2016
Reiterated: Buy
Price Target: $125
Current: $91.35
Upside: n/a